Short-, Mid-, and Long-Term Efficacy of Deucravacitinib Versus Biologics and Nonbiologics for Plaque Psoriasis: A Network Meta-Analysis

• Main Authors: April W. Armstrong (Author), Richard B. Warren (Author), Yichen Zhong (Author), Joe Zhuo (Author), Allie Cichewicz (Author), Ananth Kadambi (Author), Daniela Junqueira (Author), Tracy Westley (Author), Renata Kisa (Author), Carolin Daamen (Author), Matthias Augustin (Author)
• Format: Book
• Published: Adis, Springer Healthcare, 2023-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Introduction Deucravacitinib, a newly approved oral medication for the treatment of patients with moderate to severe plaque psoriasis, demonstrated efficacy versus apremilast and placebo in two phase 3 randomized controlled trials (RCTs). A systematic review and network meta-analysis (NMA)...